Authors

I just noticed Mark Kleiman’s post about Sativex. He does a fairly good job of summarizing the situation, and talks about how the advent of Sativex may affect the framing of the debate on both sides of the medical marijuana issue. So far, OK, (although I don’t agree with him that, for political reasons, “the […]